Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1
Clinical trial NCT02775292 · COMPLETED
Trial details
- NCT number
- NCT02775292
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-03
- Primary completion
- 2019-04-08
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.